Oruka Therapeutics Inc (ORKA)

Jan 06, 2026

Oruka Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 06, 2026

Jan 06, 2026

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jan 06, 2026

Jan 05, 2026

Oruka Therapeutics: ORKA-001 For Psoriasis In Focus As 2026 Phase 2 Data Nears - Seeking Alpha

Jan 05, 2026

Jan 05, 2026

ORKA-001 psoriasis trial: Fresh phase 2 update and what it means for investors - MSN

Jan 05, 2026

Jan 05, 2026

Oruka Therapeutics (NASDAQ:ORKA) Trading Down 8.3%What's Next? - MarketBeat

Jan 05, 2026

Jan 05, 2026

Oruka Therapeutics Builds Oncology Programs at Molecular Level - Kalkine Media

Jan 05, 2026

Jan 02, 2026

Insider Sell Alert: Laura Sandler Sells 13,000 Shares of Oruka T - GuruFocus

Jan 02, 2026

Jan 02, 2026

Oruka Therapeutics COO Sandler sells $370,795 in shares By Investing.com - Investing.com Canada

Jan 02, 2026

Jan 02, 2026

Oruka Therapeutics COO Sandler sells $370,795 in shares - Investing.com UK

Jan 02, 2026

Jan 02, 2026

Oruka Therapeutics (NASDAQ:ORKA) Stock Price Up 4.3% – Time to Buy? - Defense World

Jan 02, 2026

Dec 31, 2025

Oruka Therapeutics (NASDAQ:ORKA) Shares Up 4.3%Should You Buy? - MarketBeat

Dec 31, 2025

Dec 30, 2025

Oruka Therapeutics (NASDAQ:ORKA) Trading Down 3.3%Time to Sell? - MarketBeat

Dec 30, 2025

Dec 29, 2025

Wolfe Research Initiates Coverage of Oruka Therapeutics (ORKA) with Outperform Recommendation - MSN

Dec 29, 2025

Dec 28, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) and Oruka Therapeutics (NASDAQ:ORKA) Financial Survey - Defense World

Dec 28, 2025

Dec 26, 2025

Oruka Therapeutics inks exclusive license deal with Paragon - MSN

Dec 26, 2025

Dec 23, 2025

Oruka Therapeutics (ORKA): Valuation Check After Board Appointment of Commercial Veteran Chris Martin - Sahm

Dec 23, 2025

Dec 22, 2025

Oruka Therapeutics (NASDAQ:ORKA) Reaches New 12-Month HighHere's What Happened - MarketBeat

Dec 22, 2025

Dec 22, 2025

Oruka Therapeutics stock hits 52-week high at 32.31 USD By Investing.com - Investing.com Australia

Dec 22, 2025

Dec 22, 2025

Oruka Therapeutics stock hits 52-week high at 32.31 USD - Investing.com India

Dec 22, 2025

Dec 20, 2025

Is Oruka Therapeutics Inc. (HQ1) stock undervalued historicallyMarket Sentiment Report & Fast Exit Strategy with Risk Control - Улправда

Dec 20, 2025

Dec 20, 2025

Financial Enhancement Group LLC Takes Position in Oruka Therapeutics, Inc. $ORKA - MarketBeat

Dec 20, 2025

Dec 19, 2025

Oruka Therapeutics (NASDAQ:ORKA) Insider Sells $214,270.00 in Stock - MarketBeat

Dec 19, 2025

Dec 19, 2025

Oruka Therapeutics (NASDAQ:ORKA) Shares Up 11.3%Here's What Happened - MarketBeat

Dec 19, 2025

Dec 19, 2025

Why Oruka Therapeutics Inc. stock is a must watch in 2025Recession Risk & Real-Time Chart Pattern Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Piper Sandler Begins Coverage on Oruka Therapeutics (NASDAQ:ORKA) - MarketBeat

Dec 19, 2025

Dec 19, 2025

How Oruka Therapeutics Inc. stock compares to growth peersWeekly Gains Report & AI Based Buy and Sell Signals - Улправда

Dec 19, 2025

Dec 18, 2025

Is Oruka Therapeutics Inc. stock a dividend growth opportunityJuly 2025 PreEarnings & Weekly Chart Analysis and Trade Guides - Улправда

Dec 18, 2025

Dec 18, 2025

ORKA-001 Psoriasis Trial: Fresh Phase 2 Update and What It Means for Investors - TipRanks

Dec 18, 2025

Dec 15, 2025

Oruka Therapeutics Earnings Notes - Trefis

Dec 15, 2025

Dec 13, 2025

Braidwell LP Cuts Stake in Oruka Therapeutics, Inc. $ORKA - MarketBeat

Dec 13, 2025

Dec 12, 2025

Oruka Therapeutics appoints Chris Martin to board of directors By Investing.com - Investing.com India

Dec 12, 2025

Dec 12, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 12, 2025

Dec 11, 2025

Oruka Therapeutics appoints Chris Martin to board of directors - Investing.com

Dec 11, 2025

Dec 11, 2025

Oruka Therapeutics Appoints Christopher Martin to Board - TipRanks

Dec 11, 2025

Dec 11, 2025

Oruka Therapeutics Announces New Board Member and Board Transition - The Manila Times

Dec 11, 2025

Dec 09, 2025

B Group Inc. Increases Position in Oruka Therapeutics, Inc. $ORKA - Defense World

Dec 09, 2025

Dec 06, 2025

Oruka Therapeutics (ORKA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 06, 2025

Dec 06, 2025

Oruka Therapeutics, Inc. $ORKA Shares Purchased by Geode Capital Management LLC - Defense World

Dec 06, 2025

Dec 06, 2025

Oruka Therapeutics, Inc. $ORKA Shares Purchased by Affinity Asset Advisors LLC - Defense World

Dec 06, 2025

Dec 05, 2025

Oruka Therapeutics (NASDAQ:ORKA) Sets New 52-Week HighWhat's Next? - MarketBeat

Dec 05, 2025

Dec 05, 2025

Oruka Therapeutics stock hits 52-week high, reaching $31.01 By Investing.com - Investing.com Nigeria

Dec 05, 2025

Dec 05, 2025

Can Oruka Therapeutics Inc. stock deliver consistent earnings growthCEO Change & AI Based Buy and Sell Signals - Newser

Dec 05, 2025

Dec 04, 2025

Will Oruka Therapeutics Inc. stock sustain high P E ratios2025 Volatility Report & Safe Capital Growth Plans - Newser

Dec 04, 2025

Dec 04, 2025

Is Oruka Therapeutics Inc. (HQ1) stock dividend growth reliable2025 Risk Factors & Consistent Profit Trading Strategies - Newser

Dec 04, 2025

Dec 04, 2025

Oruka Therapeutics stock hits 52-week high, reaching $31.01 - Investing.com

Dec 04, 2025

Dec 04, 2025

Should I hold or sell Oruka Therapeutics Inc. stock in 2025Market Movement Recap & AI Based Buy and Sell Signals - Newser

Dec 04, 2025

Dec 04, 2025

Is Oruka Therapeutics Inc. (HQ1) stock undervalued at current priceJuly 2025 Snapshot & Community Verified Trade Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Is Oruka Therapeutics Inc. (HQ1) stock a momentum leaderQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser

Dec 04, 2025

Dec 03, 2025

Will Oruka Therapeutics Inc. stock see insider buyingMarket Growth Review & Consistent Profit Trading Strategies - Newser

Dec 03, 2025